RecruitingNCT07026786
This study is looking at whether an online mindfulness program can help people with Pain After Surgery or Anxiety After Surgery. Participants receive a study treatment and complete follow-up visits and assessments.
AnxietyOtherOver 18 Years
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
- Condition
- Anxiety
RecruitingNCT05895383
This observational study is following people with Procedural Pain, Pain Catastrophizing, or Procedural Anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
AnxietyOtherFrom 21 Years to 85 Years
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
- Condition
- Anxiety
RecruitingNCT05064813
This study is looking at whether a digital support tool can help people with Generalized anxiety. Participants take part in a digital support tool and complete follow-up assessments.
AnxietyOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- Anxiety
RecruitingNCT07391020
This study is looking at whether Safety Behavior Fading for Pathological Worry can help people with Generalized anxiety, Worrying, or Anxiety. Participants take part in Safety Behavior Fading for Pathological Worry and complete follow-up assessments.
AnxietyOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Florida State University
- Condition
- Anxiety
Not Yet RecruitingNCT07390487
This study is looking at evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms for people with Psoriasis or Anxiety. Participants take part in a digital support tool and complete follow-up assessments.
AnxietyOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of California, San Francisco
- Condition
- Anxiety
RecruitingNCT06595953
This study is comparing Gaze-Contingent Music Reward Therapy with Sham-GCMRT for people with anxiety. Participants receive Gaze-Contingent Music Reward Therapy or Sham-GCMRT and complete study visits and assessments.
AnxietyOtherFrom 8 Years to 17 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Anxiety
RecruitingNCT07310004
This study is looking at whether a digital support tool can help people with Breast Biopsy, Anxiety, or Pain. Participants take part in a digital support tool and complete follow-up assessments.
AnxietyOtherOver 18 Years
- Countries
- United States
- Sponsor
- Jonsson Comprehensive Cancer Center
- Condition
- Anxiety
RecruitingNCT06809179
This study is comparing Fasedienol Nasal Spray - Placebo Nasal Spray with placebo for people with Social anxiety. Participants receive Fasedienol Nasal Spray - Placebo Nasal Spray or placebo and complete study visits and assessments.
AnxietyOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- VistaGen Therapeutics, Inc.
- Condition
- Anxiety
RecruitingNCT07424404
This study is looking at care and outcomes for people with Schizophrenia or Autism-Related Irritability. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 5 Years to 17 Years
- Countries
- Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT07410507
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Argentina, Brazil, China, India, Japan, Taiwan, United States
- Sponsor
- Eli Lilly and Company
- Condition
- Schizophrenia
RecruitingNCT07290738
This study is looking at care and outcomes for people with Schizophrenia Spectrum Disorder. Some participants may receive PFC sham instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT06585787
This study is looking at how safe and effective KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD is for people with Alzheimer Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
Not Yet RecruitingNCT07488156
This study is looking at whether questionnaires and follow-up can help people with Schizophrenia Disorder, schizoaffective disorder, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Condition
- Schizophrenia
RecruitingNCT06774417
This study is looking at whether a digital support tool can help people with Clinical High Risk, Early Psychosis, or First Episode Psychosis. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 12 Years to 29 Years
- Countries
- United States
- Sponsor
- Columbia University
- Condition
- Schizophrenia
RecruitingNCT07467993
This study is looking at assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Novartis Pharmaceuticals
- Condition
- Schizophrenia
RecruitingNCT07483294
This study is looking at investigate neural markers in the cerebellar-cortical circuitry that predict treatment response to antipsychotics in first-episode psychosis for people with Psychosis or Acute. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 16 Years to 40 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
RecruitingNCT05770375
This study is looking at whether MDMA 40mg can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Anya Bershad, MD, PhD
- Condition
- Schizophrenia
RecruitingNCT07101094
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
RecruitingNCT05304767
This study is looking at whether Xanomeline and Trospium Chloride Capsules can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Czech Republic, India, Japan, Poland, Romania, Serbia, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT07221877
This study is looking at characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia. Taking part may give some people access to Xanomeline/trospium chloride, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
Active Not RecruitingNCT00001246
This observational study is following people with Attention Deficit Hyperactivity Disorder, Schizophrenia, or Attention Deficit Disorder With Hyperactivity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 3 Years to 120 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Schizophrenia
RecruitingNCT07459647
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- MapLight Therapeutics
- Condition
- Schizophrenia
RecruitingNCT07460453
This study is looking at whether a digital support tool can help people with Paranoia or psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Indiana University
- Condition
- Schizophrenia
RecruitingNCT07459660
This study is looking at whether ML-007C-MA can help people with Psychosis Associated With Alzheimer's Disease. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 55 Years to 91 Years
- Countries
- United States
- Sponsor
- MapLight Therapeutics
- Condition
- Schizophrenia
RecruitingNCT06944847
This study is looking at whether Acute (24-hour) abstinence can help people with Acute Abstinence From Cigarettes vs E-cigarettes. Participants take part in Acute (24-hour) abstinence and complete follow-up assessments.
SchizophreniaOtherFrom 21 Years to 50 Years
- Countries
- United States
- Sponsor
- State University of New York at Buffalo
- Condition
- Schizophrenia